Robert W. Hostoffer

Efficacy of benralizumab, dupilumab, and tezepelumab in severe asthma: a meta-analysis with eosinophil-stratified subgroup analysis

Abstract Context Severe asthma affects 3–10 % of all asthma patients but accounts for disproportionately high morbidity and mortality. These patients tend to experience more frequent hospitalization compared to mild-to-moderate controlled asthmatics or the general population. Despite optimized inhaler therapy, many pat...